Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
JD-010 by Beijing JD Biotech for Hematological Tumor: Likelihood of Approval
JD-010 is under clinical development by Beijing JD Biotech and currently in Phase I for Hematological Tumor. According to GlobalData,...